Veeva Systems Inc.
VEEV Healthcare Health Information Services
Veeva Systems Inc.’s revenue for fiscal 2026 (year ended January 2026) was $3.2 billion, up 16.3% from fiscal 2025. In the quarter to July 2026, revenue grew 17.6%, EPS grew 36.6% and free cash flow was flat, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for ten consecutive years, operating cash flow growth for ten.
Follow VEEV
Veeva Systems Inc. (VEEV) Price to free cash flow
As of 16 October 2026, Veeva Systems Inc. (VEEV) trades at a price to free cash flow of 30.7×. Over the past ten years it has ranged from 15.3× (June 2026) to 96.4× (October 2020); the current reading is higher than 13% of that period. That is above the Health Information Services industry median of 19.0× and above the Healthcare sector median of 20.2×.
Price to free cash flow, daily
Embed this chart
Annual newest first
| Period | Price to free cash flow | Change |
|---|---|---|
| FY2026 | 24.0× | (31.99%) |
| FY2025 | 35.3× | (6.14%) |
| FY2024 | 37.6× | 8.87% |
| FY2023 | 34.6× | (28.49%) |
| FY2022 | 48.3× | (38.50%) |
| FY2021 | 78.6× | 57.01% |
| FY2020 | 50.0× | (4.26%) |
| FY2019 | 52.3× | 31.59% |
| FY2018 | 39.7× | (5.62%) |
| FY2017 | 42.1× | (23.33%) |
Quarterly newest first
| Period | Price to free cash flow | Change |
|---|---|---|
| Jul 2026 | 20.2× | 29.97% |
| Apr 2026 | 15.5× | (35.31%) |
| Jan 2026 | 24.0× | (32.09%) |
| Oct 2025 | 35.4× | 1.06% |
| 43 more quarters | Free account |
Against its own ten years
Price to free cash flow against peers
| Company | Price to free cash flow |
|---|---|
| TEM Tempus AI, Inc. compare | n/m |
| HTFL Heartflow, Inc. compare | n/m |
| HQY HealthEquity, Inc. compare | 17.6× |
| DOCS Doximity, Inc. compare | 19.0× |
| WAY Waystar Holding Corp. compare | 21.3× |
| HNGE Hinge Health Inc. compare | 27.6× |
| VEEV Veeva Systems Inc. | 30.7× |
| BTSG BrightSpring Health Services, Inc. compare | 31.2× |
| TXG 10x Genomics compare | 75.4× |
| Health Information Services industry median | 19.0× |
| Healthcare sector median | 20.2× |
| Market median | 14.2× |
What Price to free cash flow is
Price to Free Cash Flow Ratio shows how much investors pay for each dollar of cash a company generates after its capital spending.
Stock Price ÷ ((Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM)) ÷ (Shares (Basic, Weighted) (latest quarter)))
More on VEEV
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement